4/27/2023 0 Comments Hepatite abcdBy contrast, isolated studies of HEV infection have reported high prevalence rates of between 10.4% and 16%. National surveys in Peru have revealed a high prevalence rate (98%) of HAV infection, which varies greatly, depending on age and socio-economic level. HAV and HEV infections share the fecal–oral route of transmission and generally carry low mortality rates. Due to the high burden of morbidity and mortality, the United Nations, through its health-related Sustainable Development Goals (SDGs), have urged for specific measures to be taken to combat viral hepatitis worldwide. These infections differ in disease burden and their epidemiology, as well as their clinical and virology features. Approximately 47% of deaths are attributable to hepatitis B virus (HBV) and 48% to hepatitis C virus (HCV) infections, and a smaller proportion to hepatitis A (HAV) and E virus (HEV) infections. In 2013, viral hepatitis was ranked the seventh leading cause of mortality worldwide, with an estimated death rate of 1.4 million each year from acute infections and hepatitis-associated liver cancer and cirrhosis. Viral hepatitis (hepatitis A, B, C, D and E) remains a global public health problem, comparable to other communicable diseases such as human immunodeficiency virus (HIV), tuberculosis and malaria. Applications are submitted to This study was funded by the Instituto Nacional de Salud, Peru (project OI-082-13).Ĭompeting interests: The authors have declared that no competing interests exist. For more information about data access, see. Data are provided only once a data sharing agreement is in place between Instituto Nacional de Salud (the custodian of the data) and the researchers or an institution. All interested researchers can access these data through Instituto Nacional de Salud, Peru (Cápac Yupanqui 1400 - Jesus María, Lima 11, Perú Teléfono: 5) subject to review by the Direction, ethics approval, or signing of a data sharing agreement. The data are also not available in an institutional repository, since contain potentially sensitive patient information. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.ĭata Availability: Instituto Nacional de Salud research data cannot be publicly shared at this time. Received: FebruAccepted: Published: June 15, 2020Ĭopyright: © 2020 Cabezas et al. (2020) Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study. Citation: Cabezas C, Trujillo O, Gonzales-Vivanco Á, Benites Villafane CM, Balbuena J, Borda-Olivas AO, et al.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |